Biotransformation and cardiovascular effects of arachidonic acid in the dog
- 1 March 1979
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 54 (3), 217-228
- https://doi.org/10.1016/0014-2999(79)90080-3
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOGBritish Journal of Pharmacology, 1978
- Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogsCardiovascular Research, 1978
- Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dogEuropean Journal of Pharmacology, 1978
- Modification of Prostaglandin and Thromboxane Release by Immunological Sensitisation and Successive Immunological Challenges from Guinea-Pig LungInternational Archives of Allergy and Immunology, 1978
- Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2Prostaglandins, 1977
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albuminsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acidEuropean Journal of Pharmacology, 1976
- INHIBITION BY NON-STEROID ANTI-INFLAMMATORY AGENTS OF RABBIT AORTA CONTRACTING ACTIVITY GENERATED IN BLOOD BY SLOW REACTING SUBSTANCE CBritish Journal of Pharmacology, 1974
- Prostaglandins: Their Disappearance from and Release into the CirculationNature, 1967